PTEN and breast cancer: Previous studies by our group have shown that the PTEN-deficient MDA-MB-468 breast cancer cell line exhibits high levels of basal AKT phosphorylation, and increased basal Ca2+ influx compared to the PTEN-functional MDA-MB-231 breast cancer cell line [24,25].